JP Morgan Chase’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,200
Closed -$91K 6579
2022
Q3
$91K Buy
+3,200
New +$82.3K ﹤0.01% 5323

Other funds holding CCRN

JP Morgan Chase's CCRN Position: Q1 2026 in Review

JP Morgan Chase reduced its Cross Country Healthcare (CCRN) stake by 13% in Q1 2026, selling an estimated $149K and leaving 116,670 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4548.

JP Morgan Chase first reported a position in CCRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.9M in Q4 2015. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • JP Morgan Chase held 116,670 shares of Cross Country Healthcare worth $1.1M as of Q1 2026.
  • JP Morgan Chase sold 16,673 Cross Country Healthcare shares in Q1 2026, an estimated $149K.
  • Cross Country Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4548 holding.
  • JP Morgan Chase first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Cross Country Healthcare position peaked at $47.9M in Q4 2015.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.